PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Macopharma UK Ltd
MU

Macopharma UK Ltd

London
SME

Macopharma is a major player in the blood industry, offering a range of blood processing solutions that combine expertise in disposables, equipment, software, and processing guidelines to support healthcare professionals in providing safer and higher quality blood components.

macopharma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£132.1m
Live
8
Buyers
2
12m
£8.7m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts8 / 15
  • Top buyers2
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Macopharma UK LtdUpdated 20 Jul 2026

At a glance · for buyers and watchdogs

Macopharma UK Ltd has won £132.1m across 2 public-sector buyers, with 8 live contracts. No active Companies House risk flags.

Why: top buyer NHS Blood & Transplant (NHSBT) at 82% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
8 of 15Live contracts
82%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 12
Blood Processing SolutionsSolutions for safer and higher quality blood components. ↗Bio Banking SolutionsCollection SolutionsCord Blood SolutionsExtracorporeal Photopheresis SolutionsLeukodepletion SolutionsPaediatric SolutionsPathogen Inactivation SolutionsPhlebotomy SolutionsPlatelets SolutionsSeparation SolutionsTransfer Solutions
Frameworks & DPS · 2 from notices
  • NHS National Framework Agreement for Intravenous Solutions, Topical Solutions, Urological Solutions and GelatinsNHS England · £23.9m
  • Cord Blood Collection SystemsNHS Blood & Transplant (NHSBT) · £100k

Extracted automatically from macopharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 8 live · 7 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Framework Agreement for the Supply and Support of Sterile Connection Devices
NHS Blood & Transplant (NHSBT)—01 Apr 2026£7.5m2 yrspending
Supply of Tube Sealers, PPM & Repair. PPM & Repair of Existing Tube Heat Sealers
NHS Blood & Transplant (NHSBT)—08 Dec 2025£1.1m2 yrspending
Sample Pouches for Quality Monitoring
NHS Blood & Transplant (NHSBT)—01 Dec 2025£170k2.1 yrspending
Call-off Contract for the Supply of Blood Packs
NHS Blood & Transplant (NHSBT)3314161301 Nov 2023£95.0m4 yrsLive
Call-Off Contract for Supply of Additive Solutions for the Suspension of Blood Products Lot 2
NHS Blood & Transplant (NHSBT)3319422001 Dec 2023£345k4 yrsLive
Call-Off Contract for Supply of Additive Solutions for the Suspension of Blood Products Lot 1
NHS Blood & Transplant (NHSBT)3319422001 Dec 2023£3.9m4 yrsLive
Supply of Cord Blood Collection Systems
NHS Blood & Transplant (NHSBT)3314161305 Feb 2021£91k4 yrsClosed
SAMPLE POUCHES FOR QUALITY MONITORING
NHS Blood & Transplant (NHSBT)3314000001 Mar 2020£96k3 yrsClosed
NHS National Framework Agreement for Intravenous Solutions, Topical Solutions, Urological Solutions and Gelatins
NHS England3369200001 Jun 2018£23.9m2 yrsClosed
Cord Blood Collection Systems
NHS Blood & Transplant (NHSBT)3314100022 Feb 2017£100k2 yrsClosed
Total live value £99.2m · mean award £8.8m1–10 of 15

Top buyers · 2 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS Blood & Transplant (NHSBT)
14 contracts
82%
since 2017
2
NHS England
1 contract
18%
since 2018

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
South West14 contracts
82%
Yorkshire1 contract
18%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Macopharma UK Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
NA
Non Award
No£340.0m1
CM
Crest Medical Limited
Yes£60.8m11
BB
B. BRAUN MEDICAL LIMITED
Yes£56.8m17
MI
Medline Industries Limited
Yes£49.9m20
IM
Ideal Medical Solutions
Yes£49.9m13
MU
Macopharma UK Ltd
Yes£8.7m—
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 11 May 2027
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
01986987
Status
Active
Type
Private limited
Incorporated
07 Feb 1986
Reg. office
11 Old Jewry, 8th Floor, London, EC2R 8DU
SIC codes
21100
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • HERNU, Caroline Christiane Paule — director
    Appointed 30 Sept 2021
  • SCHOENFELD, Frank Joachim — director
    Appointed 19 Jul 2021
  • PRAMEX INTERNATIONAL LTD — corporate secretary
    Appointed 07 Apr 2014
  • Mr Gérard Paul Louis Marie-Joseph Mulliez — person with significant control
    ownership of shares 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
MACOPHARMA (UK) LIMITED
01986987 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.